Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449296

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1449296

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032

PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to reach USD 14.63 Billion by 2032, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type (In House, Contract Outsourcing); By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (APIs) are essential components of animal medicines. These ingredients are responsible for producing the desired therapeutic effects and undergo rigorous testing and research before they are approved for commercial use. As the demand for animal healthcare solutions continues to increase, the market for high-quality veterinary APIs is also growing rapidly. The market is anticipated to grow owing to numerous factors such as research & development of veterinary products, increasing investment in outsourcing, facility expansion, and expenditure on animal health.

The veterinary active pharmaceutical ingredient (API) market has been driven by the operational and cost-effectiveness benefits of outsourcing the manufacturing of APIs. Animal health companies are actively seeking ways to optimize their operations and reduce costs. By outsourcing the production of veterinary APIs to specialized manufacturers, pharmaceutical companies can focus on their core strengths, including research, development, marketing, and distribution. This trend has led to a significant expansion in the veterinary API market, driven by a growing awareness of the importance of animal health and welfare.

The market for veterinary active pharmaceutical ingredients (APIs) is witnessing significant growth owing to the rising prevalence of transboundary and zoonotic diseases. These diseases pose a significant risk to both animal and human populations and can spread rapidly across borders, posing a threat to public health, global trade, and animal welfare. The use of veterinary APIs has become crucial in controlling and preventing the spread of these diseases. They play a pivotal role in treating diseased animals, developing effective treatment strategies, and reducing the severity of symptoms, which aids in the recovery of affected animals. The veterinary API manufacturing sector is highly diverse and caters to the varied health needs of different animal species. It comprises a broad spectrum of companies ranging from large multinational pharmaceutical corporations to mid-sized enterprises.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

The market is dominated by the in-house segment, mainly due to the presence of numerous leading animal health companies that have set up their own API manufacturing facilities. This strategic move has helped them ensure an uninterrupted supply chain and maintain strict control over the quality of their products.

The veterinary API manufacturing market is projected to witness substantial growth in the biological API segment in the assessment period. This growth can be attributed to the rising need for advanced biologics and vaccines for animal healthcare.

In 2023, the global market for manufacturing veterinary active pharmaceutical ingredients (API) had the anti-infective segment as the largest contributor. This was due to the significant demand for antibiotics and other anti-microbial agents to treat bacterial, fungal, and viral infections in animals.

The global market in 2023 was dominated by the North American region, primarily due to the well-established animal healthcare industries in countries such as the United States and Canada. The presence of these industries has resulted in a high demand for veterinary APIs, making North America the largest market for veterinary APIs.

The global key market players include Alivira Animal Health Ltd., Chempro Pharma Pvt. Ltd., Elanco, Excel Industries Ltd., MENADIONA, Ofichem Group, Qilu Animal Health Products Co., Ltd., Siflon Drugs, SUANFARMA, Vetpharma, Zoetis, and among others.

Polaris Market Research has segmented the Veterinary Active Pharmaceutical Ingredients Manufacturing market report based on service type, synthesis type, animal type, therapeutic category, and region:

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • In House
  • Contract Outsourcing
  • Contract Development
  • Preclinical Development
  • Clinical Development
  • Contract Manufacturing

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biological API
  • Chemical-based API
  • HPAPI

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Production Animals
  • Companion Animals

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiparasitic
  • Anti-infectives
  • NSAIDs
  • Others

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA
Product Code: PM4540

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing - Industry Snapshot
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing prevalence of transboundary and zoonotic diseases fuels veterinary active pharmaceutical ingredients manufacturing market growth
      • 4.2.1.2. The cost-effectiveness and operational advantages of outsourcing API manufacturing drives market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high cost of veterinary diagnostic and treatment hampers veterinary active pharmaceutical ingredients manufacturing market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • 5.3. In-house
    • 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-house, by Region, 2019-2032 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Contract Development
      • 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.2 Preclinical Development
      • 5.4.2.21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.3 Clinical Development
      • 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Contract Manufacturing
      • 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2019-2032 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • 6.3. Biological API
    • 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2019-2032 (USD Billion)
  • 6.4. Chemical-based API
    • 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2019-2032 (USD Billion)
  • 6.5. HPAPI
    • 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2019-2032 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 7.3. Antiparasitic
    • 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitic, by Region, 2019-2032 (USD Billion)
  • 7.4. Anti-infectives
    • 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
  • 7.5. NSAIDs
    • 7.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • 8.3. Production Animals
    • 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2019-2032 (USD Billion)
  • 8.4. Companion Animals
    • 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2019-2032 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
    • 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - U.S.
      • 9.3.5.1. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
      • 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
    • 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
      • 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
      • 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
      • 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
      • 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
      • 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
      • 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
      • 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
      • 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
      • 9.5.7.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
      • 9.5.8.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
      • 9.6.6.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
      • 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
      • 9.6.8.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
    • 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alivira Animal Health Ltd.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Chempro Pharma Pvt. Ltd
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Elanco
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Excel Industries Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. MENADIONA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Ofichem Group
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Qilu Animal Health Products Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Siflon Drugs
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SUANFARMA
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Vetpharma
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Zoetis
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
Product Code: PM4540

List of Tables

  • Table 1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 7 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 8 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 9 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 13 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 17 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 21 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 25 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 26 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 27 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 28 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 29 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 30 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 31 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 32 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 33 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 37 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 45 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 49 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 54 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 55 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 56 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 57 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 61 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 62 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 63 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 64 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 65 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 77 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 81 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 85 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 89 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 93 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 101 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 109 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 113 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Animal Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Service Type
  • Figure 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Animal Type
  • Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Synthesis Type
  • Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Therapeutic Category
  • Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2021 & 2030 (USD Billion)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!